HRP20191989T1 - Farmaceutski pripravak za uporabu u povećanju trofizma sluznice nosa - Google Patents

Farmaceutski pripravak za uporabu u povećanju trofizma sluznice nosa Download PDF

Info

Publication number
HRP20191989T1
HRP20191989T1 HRP20191989TT HRP20191989T HRP20191989T1 HR P20191989 T1 HRP20191989 T1 HR P20191989T1 HR P20191989T T HRP20191989T T HR P20191989TT HR P20191989 T HRP20191989 T HR P20191989T HR P20191989 T1 HRP20191989 T1 HR P20191989T1
Authority
HR
Croatia
Prior art keywords
alpha
hydrogenated
preparation
oil
tocopherol
Prior art date
Application number
HRP20191989TT
Other languages
English (en)
Inventor
Giorgio Panin
Domenico TESTA
Germano GUERRA
Original Assignee
Bio.Lo.Ga. S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51951918&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20191989(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio.Lo.Ga. S.R.L. filed Critical Bio.Lo.Ga. S.R.L.
Publication of HRP20191989T1 publication Critical patent/HRP20191989T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (9)

1. Pripravak za vanjsku primjenu, za uporabu u postizanju oporavka tkiva sluznice nosa poslije operacije nosa i sinusa, koja sadrži ester alfa-tokoferola s karboksilnom kiselinom formule R-COOH, u kojoj je R alkil radikal koji ima 1 do 19 atoma ugljika, ili alkenil ili alkinil radikal koji ima 2 do 19 atoma ugljika, i uljani nosač odabran iz grupe koja se sastoji od hidrogeniranog poliizobutena, hidrogeniranog polidecena i mješavina hidrogeniranog poliizobutena i/ili hidrogeniranog polidecena s hidrogeniranim poliolefinima, posebno hidrogeniranim C6-C14 poliolefinima, triglicerida kaprilne/kaprinske kiseline, biljnog ulja, ulja Adansonia digitata, ulja sjemena Adansonia digitata, kokosovog kaprilata/ kaprata, skvalana masline, skvalena masline, ulja sjemena suncokreta (Helianthus annus), ulja Simmondsia chinensis, kokosovog kaprilata, izononil izononanoata, ciklopentasiloksana, i njihovih smjesa.
2. Pripravak za vanjsku primjenu, za uporabu u liječenju kroničnog atrofičnog rinitisa, koji sadrži ester alfa-tokoferola s karboksilnom kiselinom formule R-COOH, u kojoj je R alkil radikal koji ima 1 do 19 atoma ugljika, ili alkenil ili alkinil radikal koji ima 2 do 19 atoma ugljika, i uljani nosač odabran iz grupe koja se sastoji od hidrogeniranog poliizobutena, hidrogeniranog polidecena i mješavina hidrogeniranog poliizobutena i/ili hidrogeniranog polidecena s hidrogeniranim poliolefinima, posebno hidrogeniranim C6-C14 poliolefinima, triglicerida kaprilne/kaprinske kiseline, biljnog ulja, ulja Adansonia digitata, ulja sjemena Adansonia digitata, kokosovog kaprilata/kaprata, skvalana masline, skvalena masline, ulja sjemena suncokreta (Helianthus annus), ulja Simmondsia chinensis, kokosovog kaprilata, izononil izononanoata, ciklopentasiloksana, i njihovih smjesa.
3. Pripravak za uporabu u skladu s bilo kojim od patentnih zahtjeva 1 i 2, naznačen time što je navedeni ester alfa-tokoferola alfa-tokoferil acetat, n-propionat ili linoleat, poželjno alfa-tokoferil acetat.
4. Pripravak za uporabu u skladu s bilo kojim od patentnih zahtjeva 1 do 3, naznačen time što navedeni pripravak sadrži 3% do 80% po težini navedenog estra alfa-tokoferola u odnosu na ukupnu težinu kompozicije.
5. Pripravak za uporabu u skladu s patentnim zahtjevom 4, naznačen time što navedeni pripravak sadrži 5% do 40%, poželjno 10% do 30%, po težini navedenog estra alfa-tokoferola u odnosu na ukupnu težinu kompozicije.
6. Pripravak za uporabu u skladu s bilo kojim od patentnih zahtjeva 1 do 5, naznačen time što se navedeni uljani nosač sastoji od hidrogeniranog polidecena.
7. Pripravak za uporabu u skladu s patentnim zahtjevom 6, naznačen time što je navedeni ester alfa-tokoferola alfa-tokoferil acetat.
8. Pripravak za uporabu u skladu s patentnim zahtjevom 7, koji se sastoji od alfa-tokoferil acetata i hidrogeniranog polidecena.
9. Pripravak za uporabu u skladu s patentnim zahtjevom 8, koji se sastoji od 10-30% alfa-tokoferil acetata i 70-90% hidrogeniranog polidecena.
HRP20191989TT 2014-10-22 2019-11-04 Farmaceutski pripravak za uporabu u povećanju trofizma sluznice nosa HRP20191989T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20141819 2014-10-22
EP15783971.3A EP3209294B1 (en) 2014-10-22 2015-10-02 Pharmaceutical composition for use in increasing the trophism of nasal mucosa
PCT/EP2015/072796 WO2016062522A1 (en) 2014-10-22 2015-10-02 Pharmaceutical composition for use in increasing the trophism of nasal mucosa

Publications (1)

Publication Number Publication Date
HRP20191989T1 true HRP20191989T1 (hr) 2020-02-07

Family

ID=51951918

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20191989TT HRP20191989T1 (hr) 2014-10-22 2019-11-04 Farmaceutski pripravak za uporabu u povećanju trofizma sluznice nosa

Country Status (20)

Country Link
US (1) US10226444B2 (hr)
EP (1) EP3209294B1 (hr)
CN (1) CN107438429A (hr)
AU (1) AU2015335204B2 (hr)
CA (1) CA2965184A1 (hr)
CL (1) CL2017000971A1 (hr)
CY (1) CY1122289T1 (hr)
DK (1) DK3209294T3 (hr)
EA (1) EA033078B1 (hr)
ES (1) ES2757349T3 (hr)
GE (1) GEP20186863B (hr)
HR (1) HRP20191989T1 (hr)
HU (1) HUE047203T2 (hr)
LT (1) LT3209294T (hr)
MX (1) MX2017005195A (hr)
PL (1) PL3209294T3 (hr)
PT (1) PT3209294T (hr)
RS (1) RS59496B1 (hr)
SI (1) SI3209294T1 (hr)
WO (1) WO2016062522A1 (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3026108A1 (en) 2016-06-10 2017-12-14 Clarity Cosmetics Inc. Non-comedogenic hair and scalp care formulations and method for use
IT201700047210A1 (it) 2017-05-02 2018-11-02 St Ganassini Spa Di Ricerche Biochimiche Composizione cosmetica e/o dermatologica, e suoi usi in campo cosmetico e nel trattamento coadiuvante di patologie dermatologiche
IT201900003515A1 (it) * 2019-03-11 2020-09-11 Gilas Sas Di Carcano Maria Grazia E C COMPOSIZIONE DERMO-COSMETICA PER USO TOPICO, A BASE DI VITAMINA E e/o SUOI ESTERI

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364945A (en) 1979-12-13 1982-12-21 Whittle Barry J Nasal composition for relieving nasal distress
US20100055152A1 (en) 2008-08-26 2010-03-04 Trutek Corporation Antihistamine and antihistamine-like nasal application, products, and method
IT1282778B1 (it) 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
ITMI981586A1 (it) * 1998-07-10 2000-01-10 Giorgio Panin Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
IT1393056B1 (it) * 2008-09-22 2012-04-11 Bio Lo Ga Srl Uso di vitamina e o suoi derivati per il controllo di artropodi
CN103717235A (zh) 2011-06-24 2014-04-09 埃皮托吉尼西斯有限公司 作为抗原特异性免疫调节剂的包含选择的载体、维生素、单宁和类黄酮的组合的药物组合物
FR2981273B1 (fr) 2011-10-14 2013-12-20 Gilles Andre Yves Bhat Nouvelle composition pour les muqueuses: tocopherol, macerat huileux de fleurs de calendula dans de l'huile de rose musquee, palmitate de retinol, ubiquinone, ascorbyl palmitate et lactobacillus

Also Published As

Publication number Publication date
US10226444B2 (en) 2019-03-12
AU2015335204B2 (en) 2020-10-08
ES2757349T3 (es) 2020-04-29
SI3209294T1 (sl) 2019-12-31
EA033078B1 (ru) 2019-08-30
EP3209294B1 (en) 2019-08-21
LT3209294T (lt) 2019-10-25
BR112017008070A2 (pt) 2018-02-20
EP3209294A1 (en) 2017-08-30
CY1122289T1 (el) 2021-01-27
HUE047203T2 (hu) 2020-04-28
DK3209294T3 (da) 2019-10-28
CA2965184A1 (en) 2016-04-28
AU2015335204A1 (en) 2017-04-13
RS59496B1 (sr) 2019-12-31
CN107438429A (zh) 2017-12-05
CL2017000971A1 (es) 2018-01-12
BR112017008070A8 (pt) 2022-07-05
MX2017005195A (es) 2017-10-04
EA201790447A1 (ru) 2017-09-29
PT3209294T (pt) 2019-10-08
US20170290799A1 (en) 2017-10-12
PL3209294T3 (pl) 2020-01-31
GEP20186863B (en) 2018-06-11
WO2016062522A1 (en) 2016-04-28

Similar Documents

Publication Publication Date Title
HRP20191989T1 (hr) Farmaceutski pripravak za uporabu u povećanju trofizma sluznice nosa
PH12017501328B1 (en) Self-emulsifying composition of ?-3 fatty acid
PH12016500100A1 (en) Self-emulsifying composition of omega3 fatty acid
IN2014DN08088A (hr)
EA201291108A1 (ru) Фармацевтические композиции в виде эмульсии с низким содержанием масла, содержащие прогестоген
BR112015023190A2 (pt) regulação de câncer com o uso de compostos e/ou dieta naturais
FR3024037B1 (fr) Ingredient actif cosmetique ou dermatologique comprenant un melange d'acides dicarboxyliques gras insatures, compositions le comprenant et utilisations cosmetiques ou dermatologiques
UY34899A (es) Derivados de estra-1,3,5(10), 16-tetraeno 3-sustituidos, procedimientos para su preparación, preparaciones farmacéuticas que los contienen, asi como su uso para la preparación de medicamentos
NZ716341A (en) Glyceride composition
EP2910563A8 (en) Triterpene derivative and its anti-influenza use
AR102187A1 (es) Uso de ésteres de poliglicerina autoemulsionantes hidrofóbicos como adyuvantes y agentes antideriva de pulverización
EA201591510A1 (ru) Фармацевтическая препаративная форма, содержащая фосфатидилхолин, применяемая для лечения язвенного колита
JP2016519101A5 (hr)
CL2017001417A1 (es) Conjugados de ácido benzoico, derivados de ácido benzoico y de ácidos carboxílicos heteroarilos de oximorfona, prodrogas, métodos y preparación y uso de los mismos
RU2016129079A (ru) Композиции омега-3 жирных кислот для лечения заболеваний, вызывающих поражение нервной системы
HRP20200380T1 (hr) Pripravak koji sadrži ester alfa-tokoferola za prevenciju i liječenje alergijskog rinitisa
MX2020005442A (es) FORMULACIÓN FARMACÉUTICA DE 3A-ETINIL-3ß-HIDROXIANDROSTAN-17-ONA OXIMA.
MX2016013190A (es) Formulacion homogenea que comprende acido graso poliinsaturado omega-3 y resveratrol para administracion oral.
HRP20220808T1 (hr) Formulacija na bazi vitamina e ili njegovog estera za liječenje bakterijskih i gljivičnih biofilmova
BR112014022687A8 (pt) uso de uma quantidade eficaz de r-p88 ou um sal farmaceuticamente aceitável do mesmo, ou um éster do mesmo ou um sal farmaceuticamente aceitável de um éster do mesmo, composição farmacêutica, r-p88 ou um sal farmaceuticamente aceitável do mesmo, ou um éster do mesmo ou um sal farmaceuticamente aceitável de um éster do mesmo
UY36227A (es) Composición para uso en la prevención y tratamiento de rinitis alérgica
PH12014502817A1 (en) Compounds from the fruits of acrocomia crispa and acrocomia aculeata for use against oxidative stress and inflammation
MY178089A (en) Glyceride composition
RS20140351A1 (en) BIOCOMPATIBLE MICROEMULSION SYSTEMS WITH CONTROLLED RELEASE OF IBUPROFEN, THEIR PRODUCTION AND USE